Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TSX Implants

K-Number: K220978 · 2022-09-14

Decision Date2022-09-14
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

TSX Implants is a medical device manufactured by Biomet 3i, LLC. It received FDA 510(k) clearance on 2022-09-14 under approval number K220978. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TSX Implants?

TSX Implants is a medical device that received FDA 510(k) clearance on 2022-09-14. It is manufactured by Biomet 3i, LLC. The 510(k) number is K220978.

When was TSX Implants approved by the FDA?

TSX Implants received FDA 510(k) clearance on 2022-09-14, under approval number K220978.

What company makes TSX Implants?

TSX Implants is manufactured by Biomet 3i, LLC.

What is the FDA product code for TSX Implants?

The FDA product code for TSX Implants is DZE.

Other Devices by Biomet 3i, LLC

View all 7 devices →

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.